Keson-Brookes Maiken 4
4 · Mural Oncology plc · Filed Dec 18, 2023
Insider Transaction Report
Form 4
Keson-Brookes Maiken
See Remarks
Transactions
- Award
Stock Option (right to buy)
2023-12-14+54,242→ 54,242 totalExercise: $3.61Exp: 2033-12-13→ Ordinary Shares (54,242 underlying) - Award
Ordinary Shares
2023-12-14+29,207→ 29,207 total
Footnotes (2)
- [F1]Consists of ordinary shares issuable under 29,207 restricted stock units ("RSUs"). Each RSU represents the right to receive one ordinary share upon vesting. The RSUs are scheduled to vest with respect to 25% of the underlying ordinary shares on each of the first four anniversaries of July 17, 2023, subject to the reporting person's continued service with the Issuer.
- [F2]This option was granted on December 14, 2023. The option is scheduled to vest with respect to 25% of the underlying ordinary shares on July 17, 2024 and the remaining 75% of the underlying ordinary shares shall vest in 12 equal quarterly installments thereafter, subject to the reporting person's continued service with the Issuer.